These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25975986)

  • 1. The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors.
    Scartozzi M; Giampieri R; Aprile G; Iacono D; Santini D; dell'Aquila E; Silvestris N; Gnoni A; Bonotto M; Puzzoni M; Demurtas L; Cascinu S
    Expert Rev Mol Diagn; 2015; 15(8):979-87. PubMed ID: 25975986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
    Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
    Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive and prognostic roles of BRAF mutation in patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a meta-analysis.
    Xu Q; Xu AT; Zhu MM; Tong JL; Xu XT; Ran ZH
    J Dig Dis; 2013 Aug; 14(8):409-16. PubMed ID: 23615046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BRAF V600E-mutant colorectal cancers: Where are we?].
    Lièvre A; de la Fouchardière C; Samalin E; Benoist S; Phelip JM; André T; Lledo G
    Bull Cancer; 2020 Sep; 107(9):881-895. PubMed ID: 32674932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF V600E mutation-specific antibody: A review.
    Ritterhouse LL; Barletta JA
    Semin Diagn Pathol; 2015 Sep; 32(5):400-8. PubMed ID: 25744437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.
    Sorbye H; Dragomir A; Sundström M; Pfeiffer P; Thunberg U; Bergfors M; Aasebø K; Eide GE; Ponten F; Qvortrup C; Glimelius B
    PLoS One; 2015; 10(6):e0131046. PubMed ID: 26121270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: an analysis of the AIO KRK-0104-trial.
    Modest DP; Jung A; Moosmann N; Laubender RP; Giessen C; Schulz C; Haas M; Neumann J; Boeck S; Kirchner T; Heinemann V; Stintzing S
    Int J Cancer; 2012 Aug; 131(4):980-6. PubMed ID: 21960311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].
    Cohen R; Cervera P; Svrcek M; Dumont C; Garcia ML; Chibaudel B; de Gramont A; Pocard M; Duval A; Fléjou JF; André T
    Bull Cancer; 2015 Jun; 102(6 Suppl 1):S72-81. PubMed ID: 26118880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New Treatment Strategies for BRAF Mutation-Positive Colorectal Cancer].
    Kawakami H; Ogata S
    Gan To Kagaku Ryoho; 2021 Jun; 48(6):787-795. PubMed ID: 34139726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of EGFR antibody in non-V600 BRAF mutant metastatic colorectal cancer.
    Wang Y; Jones JC; Kipp BR; Grothey A
    Ann Oncol; 2019 Jan; 30(1):147-149. PubMed ID: 30364934
    [No Abstract]   [Full Text] [Related]  

  • 11. BRAF-mutant colorectal cancer, a different breed evolving.
    Lai E; Pretta A; Impera V; Mariani S; Giampieri R; Casula L; Pusceddu V; Coni P; Fanni D; Puzzoni M; Demurtas L; Ziranu P; Faa G; Scartozzi M
    Expert Rev Mol Diagn; 2018 Jun; 18(6):499-512. PubMed ID: 29708446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line therapy for metastatic colorectal cancer: Current perspectives and future directions.
    Burge M; Price T; Karapetis CS
    Asia Pac J Clin Oncol; 2019 Feb; 15 Suppl 1():3-14. PubMed ID: 30758881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF-Like Colorectal Cancer Cells Are Selectively Dependent on RANBP2.
    Cancer Discov; 2016 Jun; 6(6):OF18. PubMed ID: 27102074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice.
    Santini D; Spoto C; Loupakis F; Vincenzi B; Silvestris N; Cremolini C; Canestrari E; Graziano F; Galluccio N; Salvatore L; Caraglia M; Zito FA; Colucci G; Falcone A; Tonini G; Ruzzo A
    Ann Oncol; 2010 Jul; 21(7):1565. PubMed ID: 20573852
    [No Abstract]   [Full Text] [Related]  

  • 15. BRAF V600E mutated metastatic colorectal cancer: current progress and future directions.
    Kam AE; Eng C
    Expert Opin Biol Ther; 2021 Oct; 21(10):1311-1313. PubMed ID: 33761808
    [No Abstract]   [Full Text] [Related]  

  • 16. LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support
    Miller SA; Policastro RA; Sriramkumar S; Lai T; Huntington TD; Ladaika CA; Kim D; Hao C; Zentner GE; O'Hagan HM
    Cancer Res; 2021 Jul; 81(14):3791-3805. PubMed ID: 34035083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ⅱ.BRAF-Mutated Colorectal Cancer-Up-to-Date Evidence and Clinical Practice].
    Okura M; Mitani S
    Gan To Kagaku Ryoho; 2022 Nov; 49(11):1216-1220. PubMed ID: 36412023
    [No Abstract]   [Full Text] [Related]  

  • 18. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply.
    Kopetz S; Grothey A; Tabernero J
    N Engl J Med; 2020 Feb; 382(9):877-878. PubMed ID: 32101678
    [No Abstract]   [Full Text] [Related]  

  • 19. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
    Pietrantonio F
    N Engl J Med; 2020 Feb; 382(9):876-877. PubMed ID: 32101677
    [No Abstract]   [Full Text] [Related]  

  • 20. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
    Prasad V
    N Engl J Med; 2020 Feb; 382(9):876. PubMed ID: 32101676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.